Elevation Oncology Ownership 2024 | Who Owns Elevation Oncology Now?
Institutional Ownership
83.17%
Insider Ownership
0.24%
Retail Ownership
16.59%
Institutional Holders
78.00
Elevation Oncology Institutional Shareholders
Institutional Shareholders by % of Total Shares
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| LOGOS GLOBAL MANAGEMENT LP | 6.52% | 0.84% | 3,850,000 | 2,850,000 | 285.00% | 10,395,000 | Jun 30, 2024 |
| FARALLON CAPITAL MANAGEMENT LLC | 6.10% | 0.05% | 3,598,418 | -288,245 | -7.42% | 9,715,729 | Jun 30, 2024 |
| TANG CAPITAL MANAGEMENT LLC | 5.18% | 0.84% | 3,060,000 | - | - | 8,262,000 | Jun 30, 2024 |
| FRAZIER LIFE SCIENCES MANAGEMENT, L.P. | 5.01% | 0.37% | 2,958,579 | 2,958,579 | 100.00% | 7,988,163 | Jun 30, 2024 |
| AISLING CAPITAL MANAGEMENT LP | 4.80% | 3.31% | 2,834,910 | - | - | 7,654,257 | Jun 30, 2024 |
| BLACKROCK INC. | 4.22% | 0.00% | 2,490,249 | 2,318,348 | 1348.65% | 6,723,672 | Jun 30, 2024 |
| BALYASNY ASSET MANAGEMENT L.P. | 4.21% | 0.01% | 2,483,645 | -571,834 | -18.71% | 6,705,842 | Jun 30, 2024 |
| BRAIDWELL LP | 4.20% | 0.21% | 2,477,614 | 99,967 | 4.20% | 6,689,558 | Jun 30, 2024 |
| VENBIO PARTNERS LLC | 4.12% | 2.84% | 2,434,255 | -261,878 | -9.71% | 6,572,489 | Jun 30, 2024 |
| HUDSON BAY CAPITAL MANAGEMENT LP | 4.06% | 0.03% | 2,397,768 | 886,867 | 58.70% | 6,473,974 | Jun 30, 2024 |
| BVF INC/IL | 3.92% | 0.17% | 2,312,200 | - | - | 6,242,940 | Jun 30, 2024 |
| VANGUARD GROUP INC | 3.25% | 0.00% | 1,917,043 | 384,998 | 25.13% | 5,176,016 | Jun 30, 2024 |
| DARWIN GLOBAL MANAGEMENT, LTD. | 3.25% | 0.56% | 1,916,290 | -416,638 | -17.86% | 4,809,888 | Jun 30, 2024 |
| PALO ALTO INVESTORS LP | 3.05% | 0.56% | 1,800,106 | 453,440 | 33.67% | 4,860,286 | Jun 30, 2024 |
| POINT72 ASSET MANAGEMENT, L.P. | 2.85% | 0.01% | 1,680,230 | -1,687,970 | -50.11% | 4,536,621 | Jun 30, 2024 |
| AFFINITY ASSET ADVISORS, LLC | 2.49% | 0.46% | 1,468,825 | 200,000 | 15.76% | 3,965,828 | Jun 30, 2024 |
| MORGAN STANLEY | 2.16% | 0.00% | 1,273,563 | 1,245,491 | 4436.77% | 3,438,620 | Jun 30, 2024 |
| GEODE CAPITAL MANAGEMENT, LLC | 1.75% | 0.00% | 1,031,576 | 683,143 | 196.06% | 2,785,502 | Jun 30, 2024 |
| ARTAL GROUP S.A. | 1.72% | 0.07% | 1,013,015 | -500,000 | -33.05% | 2,735,141 | Jun 30, 2024 |
| ORBIMED ADVISORS LLC | 1.59% | 0.05% | 941,275 | - | - | 2,541,443 | Jun 30, 2024 |
Elevation Oncology's largest institutional shareholder is LOGOS GLOBAL MANAGEMENT LP, holding 6.52% of the company's total share outstanding, currently valued at $10.39M. The top 10 institutional shareholders own together 48.43% of the company.
Institutional Shareholders by % of Total Assets
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| AISLING CAPITAL MANAGEMENT LP | 4.80% | 3.31% | 2,834,910 | - | - | 7,654,257 | Jun 30, 2024 |
| VENBIO PARTNERS LLC | 4.12% | 2.84% | 2,434,255 | -261,878 | -9.71% | 6,572,489 | Jun 30, 2024 |
| VELAN CAPITAL INVESTMENT MANAGEMENT LP | 1.01% | 0.92% | 597,299 | 100,000 | 20.11% | 1,612,707 | Jun 30, 2024 |
| EXOME ASSET MANAGEMENT LLC | 0.63% | 0.87% | 369,322 | - | - | 997,170 | Jun 30, 2024 |
| LOGOS GLOBAL MANAGEMENT LP | 6.52% | 0.84% | 3,850,000 | 2,850,000 | 285.00% | 10,395,000 | Jun 30, 2024 |
| TANG CAPITAL MANAGEMENT LLC | 5.18% | 0.84% | 3,060,000 | - | - | 8,262,000 | Jun 30, 2024 |
| PALO ALTO INVESTORS LP | 3.05% | 0.56% | 1,800,106 | 453,440 | 33.67% | 4,860,286 | Jun 30, 2024 |
| DARWIN GLOBAL MANAGEMENT, LTD. | 3.25% | 0.56% | 1,916,290 | -416,638 | -17.86% | 4,809,888 | Jun 30, 2024 |
| GHOST TREE CAPITAL, LLC | 1.02% | 0.51% | 600,000 | 350,000 | 140.00% | 1,620,000 | Jun 30, 2024 |
| AFFINITY ASSET ADVISORS, LLC | 2.49% | 0.46% | 1,468,825 | 200,000 | 15.76% | 3,965,828 | Jun 30, 2024 |
| FRAZIER LIFE SCIENCES MANAGEMENT, L.P. | 5.01% | 0.37% | 2,958,579 | 2,958,579 | 100.00% | 7,988,163 | Jun 30, 2024 |
| IKARIAN CAPITAL, LLC | 1.17% | 0.32% | 690,089 | 542,000 | 366.00% | 1,863,242 | Jun 30, 2024 |
| OCTAGON CAPITAL ADVISORS LP | 1.27% | 0.32% | 747,000 | 747,000 | 100.00% | 2,016,900 | Jun 30, 2024 |
| BRAIDWELL LP | 4.20% | 0.21% | 2,477,614 | 99,967 | 4.20% | 6,689,558 | Jun 30, 2024 |
| BVF INC/IL | 3.92% | 0.17% | 2,312,200 | - | - | 6,242,940 | Jun 30, 2024 |
| SPHERA FUNDS MANAGEMENT LTD. | 0.56% | 0.12% | 330,000 | -100,000 | -23.26% | 891,000 | Jun 30, 2024 |
| ARTAL GROUP S.A. | 1.72% | 0.07% | 1,013,015 | -500,000 | -33.05% | 2,735,141 | Jun 30, 2024 |
| ORBIMED ADVISORS LLC | 1.59% | 0.05% | 941,275 | - | - | 2,541,443 | Jun 30, 2024 |
| FARALLON CAPITAL MANAGEMENT LLC | 6.10% | 0.05% | 3,598,418 | -288,245 | -7.42% | 9,715,729 | Jun 30, 2024 |
| ADAR1 CAPITAL MANAGEMENT, LLC | 0.14% | 0.04% | 84,927 | 76,298 | 884.20% | 229,303 | Jun 30, 2024 |
The largest Elevation Oncology shareholder by % of total assets is AISLING CAPITAL MANAGEMENT LP. The company owns 2.83M shares of Elevation Oncology (ELEV), representing 3.31% of its total assets.
Institutional Buyers
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| FRAZIER LIFE SCIENCES MANAGEMENT, L.P. | 5.01% | 0.37% | 2,958,579 | 2,958,579 | 100.00% | 7,988,163 | Jun 30, 2024 |
| LOGOS GLOBAL MANAGEMENT LP | 6.52% | 0.84% | 3,850,000 | 2,850,000 | 285.00% | 10,395,000 | Jun 30, 2024 |
| BLACKROCK INC. | 4.22% | 0.00% | 2,490,249 | 2,318,348 | 1348.65% | 6,723,672 | Jun 30, 2024 |
| MORGAN STANLEY | 2.16% | 0.00% | 1,273,563 | 1,245,491 | 4436.77% | 3,438,620 | Jun 30, 2024 |
| HUDSON BAY CAPITAL MANAGEMENT LP | 4.06% | 0.03% | 2,397,768 | 886,867 | 58.70% | 6,473,974 | Jun 30, 2024 |
| STATE STREET CORP | 1.52% | 0.00% | 897,033 | 786,433 | 711.06% | 2,421,989,000 | Jun 30, 2024 |
| OCTAGON CAPITAL ADVISORS LP | 1.27% | 0.32% | 747,000 | 747,000 | 100.00% | 2,016,900 | Jun 30, 2024 |
| GEODE CAPITAL MANAGEMENT, LLC | 1.75% | 0.00% | 1,031,576 | 683,143 | 196.06% | 2,785,502 | Jun 30, 2024 |
| IKARIAN CAPITAL, LLC | 1.17% | 0.32% | 690,089 | 542,000 | 366.00% | 1,863,242 | Jun 30, 2024 |
| PALO ALTO INVESTORS LP | 3.05% | 0.56% | 1,800,106 | 453,440 | 33.67% | 4,860,286 | Jun 30, 2024 |
| VANGUARD GROUP INC | 3.25% | 0.00% | 1,917,043 | 384,998 | 25.13% | 5,176,016 | Jun 30, 2024 |
| GHOST TREE CAPITAL, LLC | 1.02% | 0.51% | 600,000 | 350,000 | 140.00% | 1,620,000 | Jun 30, 2024 |
| SCHONFELD STRATEGIC ADVISORS LLC | 0.65% | 0.01% | 386,400 | 209,969 | 119.01% | 1,043,280 | Jun 30, 2024 |
| AFFINITY ASSET ADVISORS, LLC | 2.49% | 0.46% | 1,468,825 | 200,000 | 15.76% | 3,965,828 | Jun 30, 2024 |
| BANK OF NEW YORK MELLON CORP | 0.32% | 0.00% | 153,586 | 153,586 | 100.00% | 414,683 | Jun 30, 2024 |
| BOOTHBAY FUND MANAGEMENT, LLC | 0.31% | 0.01% | 183,493 | 144,117 | 366.00% | 495,431 | Jun 30, 2024 |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 0.23% | 0.00% | 134,546 | 134,546 | 100.00% | 363,274 | Jun 30, 2024 |
| AMERIPRISE FINANCIAL INC | 0.24% | 0.00% | 141,329 | 121,026 | 596.10% | 381,589 | Jun 30, 2024 |
| WELLINGTON MANAGEMENT GROUP LLP | 0.20% | 0.00% | 116,068 | 116,068 | 100.00% | 313,384 | Jun 30, 2024 |
| VELAN CAPITAL INVESTMENT MANAGEMENT LP | 1.01% | 0.92% | 597,299 | 100,000 | 20.11% | 1,612,707 | Jun 30, 2024 |
As of Jun 30 2024, Elevation Oncology's largest institutional buyer is FRAZIER LIFE SCIENCES MANAGEMENT, L.P.. The company purchased 2.96M stocks of ELEV, valued at $7.99M.
Institutional Sellers
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| POINT72 ASSET MANAGEMENT, L.P. | 2.85% | 0.01% | 1,680,230 | -1,687,970 | -50.11% | 4,536,621 | Jun 30, 2024 |
| LAURION CAPITAL MANAGEMENT LP | - | - | - | -888,889 | -100.00% | - | Jun 30, 2024 |
| MILLENNIUM MANAGEMENT LLC | - | - | - | -668,573 | -100.00% | - | Jun 30, 2024 |
| BALYASNY ASSET MANAGEMENT L.P. | 4.21% | 0.01% | 2,483,645 | -571,834 | -18.71% | 6,705,842 | Jun 30, 2024 |
| ARTAL GROUP S.A. | 1.72% | 0.07% | 1,013,015 | -500,000 | -33.05% | 2,735,141 | Jun 30, 2024 |
| DARWIN GLOBAL MANAGEMENT, LTD. | 3.25% | 0.56% | 1,916,290 | -416,638 | -17.86% | 4,809,888 | Jun 30, 2024 |
| FARALLON CAPITAL MANAGEMENT LLC | 6.10% | 0.05% | 3,598,418 | -288,245 | -7.42% | 9,715,729 | Jun 30, 2024 |
| VENBIO PARTNERS LLC | 4.12% | 2.84% | 2,434,255 | -261,878 | -9.71% | 6,572,489 | Jun 30, 2024 |
| WALLEYE CAPITAL LLC | 1.04% | 0.00% | 615,837 | -170,747 | -21.71% | 1,662,760 | Jun 30, 2024 |
| HRT FINANCIAL LP | - | - | - | -133,268 | -100.00% | - | Jun 30, 2024 |
| MAN GROUP PLC | - | - | - | -121,232 | -100.00% | - | Jun 30, 2024 |
| JPMORGAN CHASE & CO | 0.04% | - | 22,233 | -114,976 | -83.80% | 60,029 | Jun 30, 2024 |
| UBS GROUP AG | 0.03% | - | 15,829 | -106,736 | -87.09% | 42,738 | Jun 30, 2024 |
| SPHERA FUNDS MANAGEMENT LTD. | 0.56% | 0.12% | 330,000 | -100,000 | -23.26% | 891,000 | Jun 30, 2024 |
| MARSHALL WACE, LLP | 0.06% | 0.00% | 37,738 | -94,958 | -71.56% | 101,893 | Jun 30, 2024 |
| BANK OF AMERICA CORP /DE/ | 0.31% | - | 183,728 | -61,604 | -25.11% | 496,066 | Jun 30, 2024 |
| POLAR ASSET MANAGEMENT PARTNERS INC. | - | - | - | -54,700 | -100.00% | - | Jun 30, 2024 |
| SQUAREPOINT OPS LLC | 0.03% | 0.00% | 18,062 | -51,239 | -73.94% | 48,767 | Jun 30, 2024 |
| GOLDMAN SACHS GROUP INC | 0.85% | 0.00% | 504,131 | -46,948 | -8.52% | 1,361,154 | Jun 30, 2024 |
| BREVAN HOWARD CAPITAL MANAGEMENT LP | - | - | - | -28,358 | -100.00% | - | Jun 30, 2024 |
As of Jun 30 2024, Elevation Oncology's biggest institutional seller is POINT72 ASSET MANAGEMENT, L.P.. The company sold -1.69M shares of ELEV, valued at $4.54M.
Institutional New positions
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| FRAZIER LIFE SCIENCES MANAGEMENT, L.P. | 5.01% | 0.37% | 2,958,579 | 2,958,579 | 100.00% | 7,988,163 | Jun 30, 2024 |
| OCTAGON CAPITAL ADVISORS LP | 1.27% | 0.32% | 747,000 | 747,000 | 100.00% | 2,016,900 | Jun 30, 2024 |
| BANK OF NEW YORK MELLON CORP | 0.32% | 0.00% | 153,586 | 153,586 | 100.00% | 414,683 | Jun 30, 2024 |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 0.23% | 0.00% | 134,546 | 134,546 | 100.00% | 363,274 | Jun 30, 2024 |
| WELLINGTON MANAGEMENT GROUP LLP | 0.20% | 0.00% | 116,068 | 116,068 | 100.00% | 313,384 | Jun 30, 2024 |
| NUVEEN ASSET MANAGEMENT, LLC | 0.14% | 0.00% | 81,187 | 81,187 | 100.00% | 219,205 | Jun 30, 2024 |
| RHUMBLINE ADVISERS | 0.14% | 0.00% | 64,910 | 64,910 | 100.00% | 175,251 | Jun 30, 2024 |
| ALPINE GLOBAL MANAGEMENT, LLC | 0.08% | 0.02% | 50,103 | 50,103 | 100.00% | 135,278 | Jun 30, 2024 |
| JUMP FINANCIAL, LLC | 0.08% | 0.00% | 49,455 | 49,455 | 100.00% | 133,528 | Jun 30, 2024 |
| NEW YORK STATE COMMON RETIREMENT FUND | 0.08% | 0.00% | 39,900 | 39,900 | 100.00% | 108,000 | Jun 30, 2024 |
| XTX TOPCO LTD | 0.06% | 0.01% | 38,179 | 38,179 | 100.00% | 103,083 | Jun 30, 2024 |
| DEUTSCHE BANK AG\ | 0.05% | - | 29,020 | 29,020 | 100.00% | 78,354 | Jun 30, 2024 |
| COREBRIDGE FINANCIAL, INC. | 0.05% | 0.00% | 28,066 | 28,066 | 100.00% | 76,059 | Jun 30, 2024 |
| INVESCO LTD. | 0.04% | - | 24,563 | 24,563 | 100.00% | 66,320 | Jun 30, 2024 |
| DYNAMIC TECHNOLOGY LAB PRIVATE LTD | 0.04% | 0.01% | 22,020 | 22,020 | 100.00% | 59,000 | Jun 30, 2024 |
| VOYA INVESTMENT MANAGEMENT LLC | 0.03% | 0.00% | 18,477 | 18,477 | 100.00% | 49,888 | Jun 30, 2024 |
| BARCLAYS PLC | 0.03% | - | 17,910 | 17,910 | 100.00% | 49,000 | Jun 30, 2024 |
| METLIFE INVESTMENT MANAGEMENT, LLC | 0.02% | 0.00% | 14,465 | 14,465 | 100.00% | 39,056 | Jun 30, 2024 |
| MARATHON TRADING INVESTMENT MANAGEMENT LLC | 0.02% | 0.00% | 13,705 | 13,705 | 100.00% | 37,004 | Jun 30, 2024 |
| MERCER GLOBAL ADVISORS INC /ADV | 0.02% | 0.00% | 10,500 | 10,500 | 100.00% | 28,350 | Jun 30, 2024 |
| STRS OHIO | 0.02% | 0.00% | 9,700 | 9,700 | 100.00% | 26,190,000 | Jun 30, 2024 |
| LEGAL & GENERAL GROUP PLC | 0.01% | - | 5,287 | 5,287 | 100.00% | 14,275 | Jun 30, 2024 |
| AMERITAS INVESTMENT PARTNERS, INC. | 0.01% | 0.00% | 5,111 | 5,111 | 100.00% | 13,800 | Jun 30, 2024 |
| ROYAL BANK OF CANADA | 0.01% | - | 4,907 | 4,907 | 100.00% | 13,000 | Jun 30, 2024 |
| CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM | 0.01% | - | 3,780 | 3,780 | 100.00% | 10,206 | Jun 30, 2024 |
| AMALGAMATED BANK | 0.00% | - | 1,805 | 1,805 | 100.00% | 5,000 | Jun 30, 2024 |
| FMR LLC | - | - | 5 | 5 | 100.00% | 14 | Jun 30, 2024 |
Elevation Oncology's largest new institutional shareholder by number of shares is FRAZIER LIFE SCIENCES MANAGEMENT, L.P., purchased 2.96M shares, valued at $7.99M, as of undefined.
Institutional Sold Out
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| LAURION CAPITAL MANAGEMENT LP | - | - | - | -888,889 | -100.00% | - | Jun 30, 2024 |
| MILLENNIUM MANAGEMENT LLC | - | - | - | -668,573 | -100.00% | - | Jun 30, 2024 |
| HRT FINANCIAL LP | - | - | - | -133,268 | -100.00% | - | Jun 30, 2024 |
| MAN GROUP PLC | - | - | - | -121,232 | -100.00% | - | Jun 30, 2024 |
| POLAR ASSET MANAGEMENT PARTNERS INC. | - | - | - | -54,700 | -100.00% | - | Jun 30, 2024 |
| BREVAN HOWARD CAPITAL MANAGEMENT LP | - | - | - | -28,358 | -100.00% | - | Jun 30, 2024 |
| BANK OF MONTREAL /CAN/ | - | - | - | -22,600 | -100.00% | - | Jun 30, 2024 |
| Y-INTERCEPT (HONG KONG) LTD | - | - | - | -21,805 | -100.00% | - | Jun 30, 2024 |
| CAMBRIDGE INVESTMENT RESEARCH ADVISORS, INC. | - | - | - | -16,242 | -100.00% | - | Jun 30, 2024 |
| SG AMERICAS SECURITIES, LLC | - | - | - | -12,244 | -100.00% | - | Jun 30, 2024 |
| CTC ALTERNATIVE STRATEGIES, LTD. | - | - | - | -11,100 | -100.00% | - | Jun 30, 2024 |
| MACQUARIE GROUP LTD | - | - | - | -1,274 | -100.00% | - | Jun 30, 2024 |
Elevation Oncology's largest sold out institutional shareholder by shares sold is LAURION CAPITAL MANAGEMENT LP, sold -0.89M shares, valued at -, as of undefined.
Elevation Oncology Mutual Fund Holders
| Name | % Total Assets | Total Shares | Change Amount | Change % | Date |
|---|---|---|---|---|---|
| BRIDGEWAY FUNDS INC | 0.04% | 100,000 | 50,000 | 100.00% | Mar 28, 2024 |
| DRIEHAUS MUTUAL FUNDS | 0.04% | 334,843 | - | - | Mar 28, 2024 |
| VANGUARD VALLEY FORGE FUNDS | 0.03% | 13,217 | - | - | Mar 31, 2024 |
| Brinker Capital Destinations Trust | 0.01% | 453,210 | - | - | Feb 29, 2024 |
| VANGUARD INDEX FUNDS | 0.00% | 1,483,580 | 22,372 | 1.53% | Mar 31, 2024 |
| FIDELITY CONCORD STREET TRUST | 0.00% | 311,115 | 94,982 | 43.95% | Feb 29, 2024 |
| VANGUARD INSTITUTIONAL INDEX FUNDS | 0.00% | 22,779 | 17,427 | 325.62% | Mar 31, 2024 |
| Virtus Event Opportunities Trust | 0.00% | 527 | - | - | Mar 28, 2024 |
| RBB FUND, INC. | 0.00% | 19,755 | - | - | Feb 29, 2024 |
| NATIONWIDE MUTUAL FUNDS | 0.00% | 23,500 | - | - | Jan 31, 2024 |
| Dimensional ETF Trust | 0.00% | 50,206 | 50,206 | - | Jan 31, 2024 |
| Series Portfolios Trust | 0.00% | 283 | - | - | Jan 31, 2024 |
| DFA INVESTMENT DIMENSIONS GROUP INC | 0.00% | 8,088 | 8,088 | - | Jan 31, 2024 |
| USAA MUTUAL FUNDS TRUST | 0.00% | 1,276 | - | - | Jan 31, 2024 |
| EQ ADVISORS TRUST | 0.00% | 5,558 | 255 | 4.81% | Mar 31, 2024 |
| iSHARES TRUST | 0.00% | 76,069 | 696 | 0.92% | Mar 31, 2024 |
| VANGUARD SCOTTSDALE FUNDS | 0.00% | 3,359 | - | - | Feb 29, 2024 |
| JOHN HANCOCK VARIABLE INSURANCE TRUST | 0.00% | 551 | - | - | Mar 31, 2024 |
Elevation Oncology's largest mutual fund holder by % of total assets is "BRIDGEWAY FUNDS INC", owning 100.00K shares, compromising 0.04% of its total assets.
Elevation Oncology Institutional Ownership Trends
Institutional Holdings Trend
| Date | Holdings | Change % |
|---|---|---|
| 30 Jun, 24 | 78 | 21.88% |
| 31 Mar, 24 | 64 | 106.45% |
| 31 Dec, 23 | 31 | -22.50% |
| 30 Sep, 23 | 40 | - |
| 30 Jun, 23 | 40 | 53.85% |
| 31 Mar, 23 | 26 | - |
| 31 Dec, 22 | 26 | 23.81% |
| 30 Sep, 22 | 21 | -16.00% |
| 30 Jun, 22 | 25 | -10.71% |
| 31 Mar, 22 | 28 | -17.65% |
| 31 Dec, 21 | 34 | 61.90% |
| 30 Sep, 21 | 21 | -41.67% |
| 30 Jun, 21 | 36 | - |
As of 30 Jun 24, 78 institutions are holding Elevation Oncology's shares, representing an increase of 21.88% compared to the previous quarter.
Shares Outstanding Trend
| Date | Shares Outstanding | Change % |
|---|---|---|
| 30 Jun, 24 | 49,086,797 | 11.57% |
| 31 Mar, 24 | 43,997,469 | 70.21% |
| 31 Dec, 23 | 25,848,863 | -7.84% |
| 30 Sep, 23 | 28,047,314 | -11.07% |
| 30 Jun, 23 | 31,538,350 | 94.54% |
| 31 Mar, 23 | 16,211,905 | 12.40% |
| 31 Dec, 22 | 14,423,778 | 1.02% |
| 30 Sep, 22 | 14,278,557 | -7.10% |
| 30 Jun, 22 | 15,370,027 | -17.86% |
| 31 Mar, 22 | 18,712,681 | 2.24% |
| 31 Dec, 21 | 18,302,591 | 15.23% |
| 30 Sep, 21 | 15,882,998 | -1.91% |
| 30 Jun, 21 | 16,192,215 | - |
Elevation Oncology (ELEV) has 49.09M shares outstanding as of 30 Jun 24, up 11.57% compared to the previous quarter.
Institutional Ownership Trend
| Date | Ownership % | Change % |
|---|---|---|
| 30 Jun, 24 | 83.17% | 0.96% |
| 31 Mar, 24 | 92.88% | 2.50% |
| 31 Dec, 23 | 60.94% | 1.39% |
| 30 Sep, 23 | 66.15% | 0.51% |
| 30 Jun, 23 | 114.37% | 2.43% |
| 31 Mar, 23 | 68.64% | 1.79% |
| 31 Dec, 22 | 61.99% | 1.65% |
| 30 Sep, 22 | 61.31% | 1.40% |
| 30 Jun, 22 | 66.08% | 1.02% |
| 31 Mar, 22 | 80.60% | 0.35% |
| 31 Dec, 21 | 150.85% | 0.88% |
| 30 Sep, 21 | 130.91% | 1.37% |
| 30 Jun, 21 | 97.92% | - |
As of 30 Jun 24, Elevation Oncology is held by 83.17% institutional shareholders, representing a 0.96% growth compared to 31 Mar 24.
Institutional Increased Positions Trend
| Date | Increased Positions | Change % |
|---|---|---|
| 30 Jun, 24 | 50 | -1.96% |
| 31 Mar, 24 | 51 | 628.57% |
| 31 Dec, 23 | 7 | -65.00% |
| 30 Sep, 23 | 20 | -25.93% |
| 30 Jun, 23 | 27 | 107.69% |
| 31 Mar, 23 | 13 | 18.18% |
| 31 Dec, 22 | 11 | 120.00% |
| 30 Sep, 22 | 5 | -50.00% |
| 30 Jun, 22 | 10 | -16.67% |
| 31 Mar, 22 | 12 | -42.86% |
| 31 Dec, 21 | 21 | 110.00% |
| 30 Sep, 21 | 10 | -72.22% |
| 30 Jun, 21 | 36 | - |
50 institutional shareholders have increased their position in ELEV stock as of 30 Jun 24 compared to 51 in the previous quarter (a -1.96% decrease).
Institutional Reduced Positions Trend
| Date | Reduced Positions | Change % |
|---|---|---|
| 30 Jun, 24 | 20 | 122.22% |
| 31 Mar, 24 | 9 | 28.57% |
| 31 Dec, 23 | 7 | 16.67% |
| 30 Sep, 23 | 6 | 20.00% |
| 30 Jun, 23 | 5 | 25.00% |
| 31 Mar, 23 | 4 | - |
| 31 Dec, 22 | 4 | -20.00% |
| 30 Sep, 22 | 5 | 25.00% |
| 30 Jun, 22 | 4 | -20.00% |
| 31 Mar, 22 | 5 | -16.67% |
| 31 Dec, 21 | 6 | 50.00% |
| 30 Sep, 21 | 4 | - |
| 30 Jun, 21 | - | - |
20 institutional shareholders have reduced their position in ELEV stock as of 30 Jun 24 compared to 9 in the previous quarter (a 122.22% increase).
All Institutional Ownership Trend Data
| Date | Holdings | Change % | Shares Outstanding | Change % | Ownership % | Change % | Increased Positions | Change % | Reduced Positions | Change % |
|---|---|---|---|---|---|---|---|---|---|---|
| 30 Jun, 24 | 78 | 21.88% | 49,086,797 | 11.57% | 83.17% | 0.96% | 50 | -1.96% | 20 | 122.22% |
| 31 Mar, 24 | 64 | 106.45% | 43,997,469 | 70.21% | 92.88% | 2.50% | 51 | 628.57% | 9 | 28.57% |
| 31 Dec, 23 | 31 | -22.50% | 25,848,863 | -7.84% | 60.94% | 1.39% | 7 | -65.00% | 7 | 16.67% |
| 30 Sep, 23 | 40 | - | 28,047,314 | -11.07% | 66.15% | 0.51% | 20 | -25.93% | 6 | 20.00% |
| 30 Jun, 23 | 40 | 53.85% | 31,538,350 | 94.54% | 114.37% | 2.43% | 27 | 107.69% | 5 | 25.00% |
| 31 Mar, 23 | 26 | - | 16,211,905 | 12.40% | 68.64% | 1.79% | 13 | 18.18% | 4 | - |
| 31 Dec, 22 | 26 | 23.81% | 14,423,778 | 1.02% | 61.99% | 1.65% | 11 | 120.00% | 4 | -20.00% |
| 30 Sep, 22 | 21 | -16.00% | 14,278,557 | -7.10% | 61.31% | 1.40% | 5 | -50.00% | 5 | 25.00% |
| 30 Jun, 22 | 25 | -10.71% | 15,370,027 | -17.86% | 66.08% | 1.02% | 10 | -16.67% | 4 | -20.00% |
| 31 Mar, 22 | 28 | -17.65% | 18,712,681 | 2.24% | 80.60% | 0.35% | 12 | -42.86% | 5 | -16.67% |
| 31 Dec, 21 | 34 | 61.90% | 18,302,591 | 15.23% | 150.85% | 0.88% | 21 | 110.00% | 6 | 50.00% |
| 30 Sep, 21 | 21 | -41.67% | 15,882,998 | -1.91% | 130.91% | 1.37% | 10 | -72.22% | 4 | - |
| 30 Jun, 21 | 36 | - | 16,192,215 | - | 97.92% | - | 36 | - | - | - |
Elevation Oncology Insider Shareholders Trades
Open Market Insider Trades
| Date | Name | Relation | Role | Transaction | Buy/Sell | Shares | Price | Value | Shares Held | Source |
|---|
Open Market Insider Buys
| Date | Name | Relation | Role | Transaction | Buy/Sell | Shares | Price | Value | Shares Held | Source |
|---|
Insider Sells
All Insider Owners Trades
The last insider sell of Elevation Oncology's stock was made by Ferra Joseph J Jr on Jun 18 2024, selling 4,628 shares at $3.23 per share (valued at $14.95K).
Elevation Oncology Insider Ownership Trends
All Insider Trades Trend
| Date | Buy | Sell | Buy/Sell Ratio |
|---|---|---|---|
| Q2 2024 | 8 | 4 | 200.00% |
| Q1 2024 | 13 | 4 | 325.00% |
| Q4 2023 | 1 | 2 | 50.00% |
| Q3 2023 | 3 | 8 | 37.50% |
| Q2 2023 | 6 | 2 | 300.00% |
| Q1 2023 | 8 | 2 | 400.00% |
| Q4 2022 | 1 | 2 | 50.00% |
| Q3 2022 | 1 | 2 | 50.00% |
| Q2 2022 | 8 | 5 | 160.00% |
| Q1 2022 | 4 | - | - |
| Q4 2021 | 1 | 1 | 100.00% |
| Q2 2021 | 19 | 21 | 90.48% |
8 total buy trades, and 4 total sell trades (buy/sell ratio of 2.00%) were made by Elevation Oncology's insiders, as of Q2 2024.
Open Market Insider Trades Trend
| Date | Buy | Sell | Buy/Sell Ratio |
|---|---|---|---|
| Q2 2024 | - | - | - |
| Q1 2024 | - | - | - |
| Q4 2023 | - | - | - |
| Q3 2023 | - | - | - |
| Q2 2023 | - | - | - |
| Q1 2023 | - | - | - |
| Q4 2022 | - | - | - |
| Q3 2022 | - | - | - |
| Q2 2022 | - | 2 | - |
| Q1 2022 | - | - | - |
| Q4 2021 | - | - | - |
| Q2 2021 | 5 | - | - |
As of Q2 2024, Insider owners conducted 0 open market buy trades and 0 open market sell trades of Elevation Oncology's stocks.
ELEV Ownership FAQ
Who Owns Elevation Oncology?
Elevation Oncology is owned by institutional shareholders (83.17%), insiders (0.24%), and public (16.59%). The largest institutional shareholder of Elevation Oncology is LOGOS GLOBAL MANAGEMENT LP (6.52% of total shares) and the top mutual fund owner is BRIDGEWAY FUNDS INC (0.04% of total shares).
Who are the major institutional shareholders of Elevation Oncology?
Elevation Oncology's major institutional shareholders are LOGOS GLOBAL MANAGEMENT LP, FARALLON CAPITAL MANAGEMENT LLC, TANG CAPITAL MANAGEMENT LLC, FRAZIER LIFE SCIENCES MANAGEMENT, L.P., and AISLING CAPITAL MANAGEMENT LP. The top five shareholders own together 27.62% of the company's share outstanding.
How many Elevation Oncology shareholders are there?
As of Jun 2024, there are 78 institutional shareholders of Elevation Oncology.
What percentage of Elevation Oncology is owned by LOGOS GLOBAL MANAGEMENT LP?
LOGOS GLOBAL MANAGEMENT LP owns 3.85M shares of Elevation Oncology, representing 6.52% of the company's total shares outstanding, valued at $10.4M (as of Jun 2024).
What percentage of Elevation Oncology is owned by FARALLON CAPITAL MANAGEMENT LLC?
As of Jun 2024, FARALLON CAPITAL MANAGEMENT LLC holds 3.6M shares of Elevation Oncology (ELEV), compromising 6.10% of the company, valued at $9.72M.
What percentage of Elevation Oncology is owned by TANG CAPITAL MANAGEMENT LLC?
TANG CAPITAL MANAGEMENT LLC is the third largest holder of Elevation Oncology. The company owns 3.06M of the company's shares outstanding (worth $8.26M).